Research Analysts Offer Predictions for Viemed Healthcare, Inc.’s FY2023 Earnings (NASDAQ:VMD)

Viemed Healthcare, Inc. (NASDAQ:VMD – Get Rating) – Analysts at Bloom Burton issued their FY2023 EPS estimates for Viemed Healthcare in a research note issued on Monday, March 6th. Bloom Burton analyst P. Pandurangan expects that the company will post earnings of $0.30 per share for the year. The consensus estimate for Viemed Healthcare’s current full-year earnings is $0.30 per share. Bloom Burton also issued estimates for Viemed Healthcare’s FY2024 earnings at $0.55 EPS.

Viemed Healthcare Price Performance

Shares of NASDAQ:VMD opened at $9.20 on Thursday. Viemed Healthcare has a 1-year low of $4.36 and a 1-year high of $9.41. The company has a market capitalization of $349.78 million, a P/E ratio of 61.33 and a beta of 1.47. The firm’s 50 day simple moving average is $8.40 and its two-hundred day simple moving average is $7.16.

Insider Buying and Selling at Viemed Healthcare

In other news, Director Timothy Smokoff sold 11,900 shares of the business’s stock in a transaction on Wednesday, December 21st. The shares were sold at an average price of $10.40, for a total value of $123,760.00. Following the transaction, the director now owns 67,332 shares of the company’s stock, valued at $700,252.80. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Insiders own 17.20% of the company’s stock.

Institutional Investors Weigh In On Viemed Healthcare

Large investors have recently bought and sold shares of the business. Jane Street Group LLC bought a new position in Viemed Healthcare during the fourth quarter valued at $147,000. Lazard Asset Management LLC bought a new position in shares of Viemed Healthcare in the fourth quarter worth about $32,000. Man Group plc bought a new position in shares of Viemed Healthcare in the fourth quarter worth about $129,000. EAM Global Investors LLC grew its holdings in shares of Viemed Healthcare by 2.7% in the fourth quarter. EAM Global Investors LLC now owns 387,850 shares of the company’s stock worth $2,940,000 after purchasing an additional 10,245 shares during the last quarter. Finally, Forager Capital Management LLC bought a new position in shares of Viemed Healthcare in the fourth quarter worth about $10,828,000. Institutional investors own 46.04% of the company’s stock.

About Viemed Healthcare

(Get Rating)

Viemed Healthcare, Inc engages in the provision of home healthcare solutions. Through its subsidiaries, it supplies home medical equipment which provides post-acute respiratory services. It also offers respiratory disease management and in-home sleep testing and sleep apnea treatment. The company was founded by Casey Hoyt, Max Hoyt, and Michael Moore in 2016 and is headquartered in Lafayette, LA.